Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Testosterone | 37 | 2024 | 2493 | 2.540 |
Why?
|
Hypogonadism | 9 | 2024 | 805 | 2.020 |
Why?
|
Androgens | 11 | 2021 | 1285 | 1.240 |
Why?
|
Nicotinamide Mononucleotide | 2 | 2023 | 17 | 1.070 |
Why?
|
NAD | 4 | 2024 | 618 | 1.000 |
Why?
|
Sarcopenia | 7 | 2021 | 376 | 0.840 |
Why?
|
Hormone Replacement Therapy | 9 | 2024 | 756 | 0.810 |
Why?
|
Apolipoproteins B | 5 | 2024 | 386 | 0.810 |
Why?
|
Prediabetic State | 2 | 2024 | 548 | 0.780 |
Why?
|
Obesity, Abdominal | 1 | 2024 | 375 | 0.760 |
Why?
|
Sex Hormone-Binding Globulin | 3 | 2022 | 554 | 0.730 |
Why?
|
Muscle Strength | 7 | 2020 | 641 | 0.720 |
Why?
|
Cholesterol, HDL | 8 | 2024 | 1820 | 0.710 |
Why?
|
Erectile Dysfunction | 1 | 2024 | 445 | 0.700 |
Why?
|
Cardiovascular Diseases | 14 | 2024 | 15638 | 0.700 |
Why?
|
Hand Strength | 5 | 2020 | 465 | 0.600 |
Why?
|
Receptors, Androgen | 2 | 2021 | 1084 | 0.570 |
Why?
|
Mobility Limitation | 6 | 2021 | 409 | 0.540 |
Why?
|
Body Composition | 9 | 2020 | 2455 | 0.520 |
Why?
|
Models, Theoretical | 2 | 2018 | 3590 | 0.470 |
Why?
|
Area Under Curve | 2 | 2018 | 1640 | 0.460 |
Why?
|
Anemia | 1 | 2023 | 1521 | 0.450 |
Why?
|
Malnutrition | 1 | 2020 | 632 | 0.430 |
Why?
|
Prostatectomy | 1 | 2021 | 1840 | 0.420 |
Why?
|
Risk Assessment | 12 | 2024 | 24311 | 0.410 |
Why?
|
Overweight | 2 | 2023 | 2428 | 0.410 |
Why?
|
Insulin Resistance | 3 | 2023 | 3974 | 0.400 |
Why?
|
Diabetes Mellitus, Type 2 | 5 | 2024 | 12242 | 0.390 |
Why?
|
Aged | 55 | 2024 | 171520 | 0.380 |
Why?
|
Renal Artery Obstruction | 3 | 2016 | 218 | 0.360 |
Why?
|
Cholesterol, LDL | 4 | 2024 | 2396 | 0.360 |
Why?
|
Coronary Disease | 2 | 2023 | 5926 | 0.350 |
Why?
|
Double-Blind Method | 19 | 2024 | 12450 | 0.330 |
Why?
|
Dietary Proteins | 3 | 2021 | 960 | 0.330 |
Why?
|
Middle Aged | 56 | 2024 | 223418 | 0.320 |
Why?
|
Biological Specimen Banks | 2 | 2024 | 783 | 0.320 |
Why?
|
Prostatic Neoplasms | 5 | 2023 | 11206 | 0.300 |
Why?
|
Consensus | 5 | 2020 | 3207 | 0.300 |
Why?
|
Myostatin | 2 | 2022 | 129 | 0.300 |
Why?
|
Independent Living | 5 | 2024 | 580 | 0.290 |
Why?
|
Atherosclerosis | 6 | 2024 | 3431 | 0.290 |
Why?
|
Male | 75 | 2024 | 364781 | 0.290 |
Why?
|
Muscle Weakness | 2 | 2020 | 415 | 0.280 |
Why?
|
Triglycerides | 3 | 2024 | 2465 | 0.280 |
Why?
|
Metabolome | 2 | 2024 | 1009 | 0.270 |
Why?
|
Exercise Therapy | 3 | 2024 | 941 | 0.260 |
Why?
|
Blood Glucose | 6 | 2024 | 6429 | 0.260 |
Why?
|
Heart | 1 | 2019 | 4451 | 0.250 |
Why?
|
Cholesterol | 3 | 2023 | 2910 | 0.250 |
Why?
|
Patient Readmission | 1 | 2020 | 3308 | 0.250 |
Why?
|
Spinal Cord Injuries | 2 | 2024 | 928 | 0.250 |
Why?
|
Albuminuria | 3 | 2018 | 658 | 0.250 |
Why?
|
Humans | 85 | 2024 | 768451 | 0.240 |
Why?
|
Cholesterol, VLDL | 1 | 2024 | 70 | 0.230 |
Why?
|
Muscle, Skeletal | 6 | 2022 | 4984 | 0.230 |
Why?
|
Apolipoprotein B-100 | 1 | 2024 | 157 | 0.220 |
Why?
|
Activities of Daily Living | 4 | 2021 | 2433 | 0.220 |
Why?
|
Urinary Retention | 1 | 2023 | 106 | 0.210 |
Why?
|
Exercise | 1 | 2019 | 5940 | 0.210 |
Why?
|
Niacinamide | 1 | 2024 | 419 | 0.200 |
Why?
|
Absorptiometry, Photon | 7 | 2024 | 1749 | 0.200 |
Why?
|
Dihydrotestosterone | 1 | 2022 | 195 | 0.200 |
Why?
|
Aging | 6 | 2018 | 8761 | 0.190 |
Why?
|
Body Mass Index | 8 | 2023 | 13030 | 0.180 |
Why?
|
Intra-Abdominal Fat | 2 | 2021 | 623 | 0.180 |
Why?
|
Tunica Media | 2 | 2011 | 111 | 0.180 |
Why?
|
Waist Circumference | 1 | 2024 | 935 | 0.180 |
Why?
|
Oxygen Consumption | 2 | 2018 | 1882 | 0.180 |
Why?
|
Accidental Falls | 3 | 2024 | 1081 | 0.180 |
Why?
|
Carotid Artery, Common | 2 | 2011 | 175 | 0.170 |
Why?
|
Hypertriglyceridemia | 1 | 2023 | 293 | 0.170 |
Why?
|
Cohort Studies | 13 | 2022 | 41797 | 0.170 |
Why?
|
Stents | 3 | 2016 | 3204 | 0.170 |
Why?
|
Lipoproteins | 2 | 2022 | 880 | 0.170 |
Why?
|
Risk Factors | 16 | 2024 | 74915 | 0.170 |
Why?
|
Androgen Antagonists | 2 | 2018 | 1418 | 0.170 |
Why?
|
HIV Infections | 3 | 2022 | 17564 | 0.160 |
Why?
|
Tunica Intima | 2 | 2011 | 459 | 0.160 |
Why?
|
Tandem Mass Spectrometry | 2 | 2022 | 1197 | 0.160 |
Why?
|
Female | 45 | 2024 | 396943 | 0.160 |
Why?
|
Particle Size | 1 | 2023 | 1654 | 0.150 |
Why?
|
Chromatography, Liquid | 4 | 2022 | 998 | 0.150 |
Why?
|
Prostate-Specific Antigen | 3 | 2023 | 2483 | 0.150 |
Why?
|
Adult | 29 | 2024 | 223542 | 0.150 |
Why?
|
Eunuchism | 1 | 2017 | 19 | 0.150 |
Why?
|
Prospective Studies | 11 | 2024 | 54914 | 0.150 |
Why?
|
Agrin | 1 | 2017 | 75 | 0.140 |
Why?
|
Asymptomatic Infections | 1 | 2018 | 134 | 0.140 |
Why?
|
Dyslipidemias | 2 | 2018 | 874 | 0.140 |
Why?
|
Hemoglobins | 1 | 2023 | 1532 | 0.140 |
Why?
|
3-Oxo-5-alpha-Steroid 4-Dehydrogenase | 1 | 2017 | 74 | 0.140 |
Why?
|
Models, Cardiovascular | 2 | 2020 | 986 | 0.140 |
Why?
|
Leuprolide | 1 | 2018 | 313 | 0.140 |
Why?
|
Aorta, Abdominal | 2 | 2017 | 627 | 0.140 |
Why?
|
Hysterectomy | 2 | 2019 | 863 | 0.140 |
Why?
|
Fatty Acid-Binding Proteins | 1 | 2018 | 294 | 0.140 |
Why?
|
Body Weight | 3 | 2023 | 4630 | 0.130 |
Why?
|
Physical Fitness | 2 | 2020 | 744 | 0.130 |
Why?
|
Activin Receptors, Type II | 1 | 2017 | 123 | 0.130 |
Why?
|
Finasteride | 1 | 2016 | 86 | 0.130 |
Why?
|
Mass Spectrometry | 1 | 2023 | 2204 | 0.130 |
Why?
|
Administration, Cutaneous | 4 | 2020 | 716 | 0.120 |
Why?
|
Erythrocyte Deformability | 1 | 2015 | 55 | 0.120 |
Why?
|
5-alpha Reductase Inhibitors | 1 | 2016 | 112 | 0.120 |
Why?
|
Cytomegalovirus Infections | 1 | 2022 | 839 | 0.120 |
Why?
|
Gels | 3 | 2023 | 421 | 0.120 |
Why?
|
Aged, 80 and over | 13 | 2024 | 59680 | 0.120 |
Why?
|
Sexual Dysfunctions, Psychological | 1 | 2016 | 191 | 0.120 |
Why?
|
Blood Viscosity | 1 | 2015 | 125 | 0.120 |
Why?
|
Exercise Test | 2 | 2020 | 2186 | 0.120 |
Why?
|
Erythropoiesis | 1 | 2018 | 694 | 0.120 |
Why?
|
Cardiovascular System | 1 | 2021 | 838 | 0.110 |
Why?
|
Erythropoietin | 1 | 2018 | 719 | 0.110 |
Why?
|
Life Support Care | 1 | 2015 | 226 | 0.110 |
Why?
|
Metabolism | 1 | 2015 | 193 | 0.110 |
Why?
|
Joints | 1 | 2015 | 324 | 0.110 |
Why?
|
Sexual Behavior | 1 | 2024 | 2200 | 0.110 |
Why?
|
Coronary Artery Disease | 3 | 2018 | 6551 | 0.110 |
Why?
|
Pulsatile Flow | 1 | 2014 | 320 | 0.110 |
Why?
|
Receptors, Fc | 1 | 2017 | 539 | 0.110 |
Why?
|
Renal Dialysis | 1 | 2022 | 1802 | 0.110 |
Why?
|
Bone Resorption | 1 | 2017 | 727 | 0.100 |
Why?
|
Quality of Life | 5 | 2022 | 13497 | 0.100 |
Why?
|
Primary Prevention | 1 | 2020 | 1189 | 0.100 |
Why?
|
Prognosis | 4 | 2024 | 30028 | 0.100 |
Why?
|
Feasibility Studies | 1 | 2024 | 5308 | 0.100 |
Why?
|
Simian Acquired Immunodeficiency Syndrome | 1 | 2017 | 545 | 0.100 |
Why?
|
Age Factors | 6 | 2020 | 18478 | 0.100 |
Why?
|
Cardiovascular Agents | 1 | 2018 | 849 | 0.100 |
Why?
|
Cardiovascular Physiological Phenomena | 1 | 2013 | 241 | 0.100 |
Why?
|
Alopecia | 1 | 2016 | 416 | 0.100 |
Why?
|
Vasodilator Agents | 1 | 2016 | 991 | 0.100 |
Why?
|
Time Factors | 7 | 2024 | 40271 | 0.100 |
Why?
|
Voice | 1 | 2015 | 268 | 0.100 |
Why?
|
Fractures, Bone | 1 | 2024 | 2063 | 0.100 |
Why?
|
Simian immunodeficiency virus | 1 | 2017 | 814 | 0.100 |
Why?
|
Hepatitis C | 1 | 2022 | 1594 | 0.100 |
Why?
|
Diabetic Nephropathies | 1 | 2018 | 975 | 0.090 |
Why?
|
Spleen | 1 | 2017 | 2298 | 0.090 |
Why?
|
Glucose | 2 | 2024 | 4355 | 0.090 |
Why?
|
Aortic Diseases | 1 | 2017 | 742 | 0.090 |
Why?
|
Monocytes | 1 | 2020 | 2591 | 0.090 |
Why?
|
Reproduction | 1 | 2015 | 646 | 0.090 |
Why?
|
Blood Pressure | 4 | 2016 | 8538 | 0.090 |
Why?
|
Cross-Sectional Studies | 7 | 2024 | 26351 | 0.090 |
Why?
|
Heart Valve Diseases | 1 | 2018 | 1033 | 0.090 |
Why?
|
Coronary Artery Bypass | 1 | 2018 | 2194 | 0.080 |
Why?
|
Blood Platelets | 1 | 2020 | 2485 | 0.080 |
Why?
|
Calcinosis | 1 | 2018 | 1485 | 0.080 |
Why?
|
Neck | 1 | 2013 | 736 | 0.080 |
Why?
|
Microcomputers | 1 | 2008 | 140 | 0.080 |
Why?
|
Ultrasonography, Doppler | 1 | 2010 | 463 | 0.080 |
Why?
|
Odds Ratio | 2 | 2018 | 9687 | 0.080 |
Why?
|
Coronary Vessels | 2 | 2017 | 3122 | 0.080 |
Why?
|
Carotid Artery, Internal | 1 | 2010 | 446 | 0.070 |
Why?
|
Aortic Valve | 1 | 2018 | 1968 | 0.070 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2020 | 3253 | 0.070 |
Why?
|
Health Status | 2 | 2018 | 4096 | 0.070 |
Why?
|
Heart Septum | 1 | 2008 | 304 | 0.070 |
Why?
|
Neutrophils | 1 | 2020 | 3790 | 0.070 |
Why?
|
Glomerular Filtration Rate | 1 | 2016 | 2226 | 0.070 |
Why?
|
ROC Curve | 2 | 2012 | 3624 | 0.070 |
Why?
|
Treatment Outcome | 11 | 2024 | 65409 | 0.070 |
Why?
|
Clostridium Infections | 1 | 2014 | 559 | 0.070 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2019 | 4419 | 0.070 |
Why?
|
Dietary Supplements | 1 | 2020 | 3445 | 0.070 |
Why?
|
Calcium | 2 | 2017 | 5793 | 0.070 |
Why?
|
Hospitalization | 2 | 2024 | 10845 | 0.070 |
Why?
|
Heart Rate | 1 | 2018 | 4218 | 0.070 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2019 | 4642 | 0.060 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2014 | 1751 | 0.060 |
Why?
|
Sex Factors | 5 | 2020 | 10647 | 0.060 |
Why?
|
Renal Insufficiency, Chronic | 2 | 2016 | 2291 | 0.060 |
Why?
|
Kaplan-Meier Estimate | 4 | 2017 | 6537 | 0.060 |
Why?
|
Peptide Fragments | 1 | 2017 | 5152 | 0.060 |
Why?
|
Parkinson Disease | 1 | 2019 | 2891 | 0.060 |
Why?
|
Obesity | 3 | 2023 | 13065 | 0.060 |
Why?
|
Luteinizing Hormone | 2 | 2018 | 821 | 0.060 |
Why?
|
Depression | 1 | 2024 | 8235 | 0.060 |
Why?
|
Lipids | 2 | 2018 | 3346 | 0.060 |
Why?
|
Respiration, Artificial | 1 | 2015 | 2723 | 0.060 |
Why?
|
Phenotype | 1 | 2022 | 16712 | 0.060 |
Why?
|
Incidence | 6 | 2024 | 21552 | 0.060 |
Why?
|
Computer Simulation | 2 | 2014 | 6278 | 0.050 |
Why?
|
Randomized Controlled Trials as Topic | 4 | 2022 | 10358 | 0.050 |
Why?
|
Mental Health | 1 | 2018 | 3271 | 0.050 |
Why?
|
Cytokines | 1 | 2018 | 7449 | 0.050 |
Why?
|
Adiposity | 2 | 2014 | 1888 | 0.050 |
Why?
|
Transdermal Patch | 1 | 2023 | 52 | 0.050 |
Why?
|
Massachusetts | 5 | 2017 | 8908 | 0.050 |
Why?
|
Musculoskeletal Diseases | 1 | 2008 | 601 | 0.050 |
Why?
|
Hypertension | 5 | 2016 | 8611 | 0.050 |
Why?
|
C-Reactive Protein | 1 | 2014 | 3854 | 0.050 |
Why?
|
Data Interpretation, Statistical | 1 | 2012 | 2705 | 0.050 |
Why?
|
Sexual Dysfunction, Physiological | 2 | 2016 | 363 | 0.050 |
Why?
|
Ventricular Remodeling | 1 | 2010 | 1280 | 0.050 |
Why?
|
User-Computer Interface | 1 | 2008 | 1397 | 0.050 |
Why?
|
Prevalence | 5 | 2020 | 15880 | 0.050 |
Why?
|
Kidney | 1 | 2017 | 7064 | 0.050 |
Why?
|
Hip Fractures | 2 | 2020 | 996 | 0.050 |
Why?
|
Liver | 1 | 2017 | 7575 | 0.050 |
Why?
|
Atrial Fibrillation | 3 | 2015 | 5162 | 0.050 |
Why?
|
Growth Differentiation Factors | 1 | 2022 | 100 | 0.050 |
Why?
|
Telemedicine | 1 | 2019 | 3104 | 0.050 |
Why?
|
Organ Size | 2 | 2017 | 2268 | 0.050 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2019 | 10784 | 0.050 |
Why?
|
Extracellular Matrix | 1 | 2009 | 1738 | 0.050 |
Why?
|
Fatigue | 2 | 2018 | 1556 | 0.050 |
Why?
|
Radius | 1 | 2024 | 443 | 0.050 |
Why?
|
Magnetic Resonance Imaging | 5 | 2019 | 36840 | 0.040 |
Why?
|
Proportional Hazards Models | 4 | 2017 | 12561 | 0.040 |
Why?
|
Logistic Models | 2 | 2012 | 13324 | 0.040 |
Why?
|
Stroke | 3 | 2023 | 9791 | 0.040 |
Why?
|
Gonadal Steroid Hormones | 1 | 2024 | 708 | 0.040 |
Why?
|
Lung | 1 | 2018 | 10090 | 0.040 |
Why?
|
Insulin | 3 | 2018 | 6606 | 0.040 |
Why?
|
Echocardiography | 2 | 2010 | 5043 | 0.040 |
Why?
|
Cardiomyopathy, Hypertrophic | 1 | 2008 | 1333 | 0.040 |
Why?
|
Menstrual Cycle | 1 | 2022 | 542 | 0.040 |
Why?
|
Postural Balance | 1 | 2024 | 638 | 0.040 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2010 | 2145 | 0.040 |
Why?
|
Depressive Disorder, Major | 1 | 2016 | 4816 | 0.040 |
Why?
|
Cognition | 1 | 2016 | 7066 | 0.040 |
Why?
|
Pelvic Floor | 1 | 2019 | 138 | 0.040 |
Why?
|
Menopause, Premature | 1 | 2019 | 124 | 0.040 |
Why?
|
Erythrocyte Count | 1 | 2018 | 157 | 0.040 |
Why?
|
Inflammation | 1 | 2018 | 10865 | 0.040 |
Why?
|
Reference Standards | 1 | 2022 | 1015 | 0.040 |
Why?
|
Young Adult | 7 | 2022 | 60045 | 0.040 |
Why?
|
Disease Progression | 4 | 2018 | 13655 | 0.040 |
Why?
|
Tibia | 1 | 2024 | 1075 | 0.040 |
Why?
|
Estradiol | 2 | 2015 | 1949 | 0.040 |
Why?
|
Heart Ventricles | 1 | 2010 | 3839 | 0.040 |
Why?
|
Bone Density | 2 | 2024 | 3561 | 0.040 |
Why?
|
Canada | 1 | 2023 | 2143 | 0.040 |
Why?
|
Multivariate Analysis | 3 | 2017 | 12096 | 0.040 |
Why?
|
Lung Volume Measurements | 1 | 2018 | 383 | 0.040 |
Why?
|
Severity of Illness Index | 3 | 2024 | 15965 | 0.040 |
Why?
|
Life Style | 1 | 2008 | 3929 | 0.030 |
Why?
|
Ventricular Function, Left | 1 | 2010 | 3941 | 0.030 |
Why?
|
Retrospective Studies | 4 | 2019 | 81834 | 0.030 |
Why?
|
Prolactin | 1 | 2018 | 626 | 0.030 |
Why?
|
Predictive Value of Tests | 3 | 2017 | 15460 | 0.030 |
Why?
|
Gait | 1 | 2021 | 822 | 0.030 |
Why?
|
Utah | 1 | 2015 | 130 | 0.030 |
Why?
|
Nutrition Surveys | 1 | 2023 | 1734 | 0.030 |
Why?
|
Ferritins | 1 | 2018 | 601 | 0.030 |
Why?
|
Follow-Up Studies | 5 | 2017 | 39430 | 0.030 |
Why?
|
Coronary Angiography | 2 | 2017 | 4526 | 0.030 |
Why?
|
Prostate | 1 | 2023 | 1781 | 0.030 |
Why?
|
Estrous Cycle | 1 | 2015 | 65 | 0.030 |
Why?
|
Glucose Tolerance Test | 1 | 2018 | 1181 | 0.030 |
Why?
|
Bone Morphogenetic Protein 7 | 1 | 2015 | 110 | 0.030 |
Why?
|
Physical Therapy Modalities | 1 | 2019 | 533 | 0.030 |
Why?
|
Aortography | 1 | 2017 | 422 | 0.030 |
Why?
|
Viremia | 1 | 2018 | 725 | 0.030 |
Why?
|
Single-Blind Method | 1 | 2019 | 1585 | 0.030 |
Why?
|
North America | 1 | 2018 | 1292 | 0.030 |
Why?
|
Sound Spectrography | 1 | 2015 | 114 | 0.030 |
Why?
|
Reference Values | 1 | 2022 | 4941 | 0.030 |
Why?
|
Brazil | 1 | 2018 | 1247 | 0.030 |
Why?
|
Walking | 1 | 2021 | 1202 | 0.030 |
Why?
|
Placebos | 1 | 2018 | 1668 | 0.030 |
Why?
|
Anthropometry | 1 | 2018 | 1343 | 0.030 |
Why?
|
Hypertrophy | 1 | 2015 | 562 | 0.030 |
Why?
|
Aminoglycosides | 1 | 2014 | 161 | 0.030 |
Why?
|
Pelvis | 1 | 2018 | 737 | 0.030 |
Why?
|
Adipose Tissue | 2 | 2015 | 3335 | 0.030 |
Why?
|
Follicle Stimulating Hormone | 1 | 2015 | 726 | 0.030 |
Why?
|
Longitudinal Studies | 2 | 2020 | 14766 | 0.030 |
Why?
|
Systems Analysis | 1 | 2013 | 168 | 0.030 |
Why?
|
Disability Evaluation | 1 | 2020 | 1839 | 0.030 |
Why?
|
Orchiectomy | 1 | 2015 | 466 | 0.030 |
Why?
|
Models, Statistical | 2 | 2020 | 5103 | 0.030 |
Why?
|
Ovariectomy | 1 | 2015 | 614 | 0.030 |
Why?
|
Geriatric Assessment | 1 | 2020 | 1422 | 0.030 |
Why?
|
Manometry | 1 | 2014 | 459 | 0.020 |
Why?
|
Bone Remodeling | 1 | 2015 | 583 | 0.020 |
Why?
|
Creatine | 1 | 2014 | 427 | 0.020 |
Why?
|
Europe | 1 | 2018 | 3439 | 0.020 |
Why?
|
Recovery of Function | 1 | 2022 | 2994 | 0.020 |
Why?
|
Voice Disorders | 1 | 2015 | 286 | 0.020 |
Why?
|
Depressive Disorder | 1 | 2024 | 3738 | 0.020 |
Why?
|
Tendons | 1 | 2015 | 559 | 0.020 |
Why?
|
HIV | 1 | 2018 | 1596 | 0.020 |
Why?
|
Confidence Intervals | 1 | 2016 | 2932 | 0.020 |
Why?
|
Ovary | 1 | 2015 | 960 | 0.020 |
Why?
|
Muscles | 1 | 2015 | 1582 | 0.020 |
Why?
|
Vancomycin | 1 | 2014 | 506 | 0.020 |
Why?
|
Ion Channels | 1 | 2015 | 1044 | 0.020 |
Why?
|
Affect | 1 | 2018 | 1498 | 0.020 |
Why?
|
Health Surveys | 1 | 2020 | 4056 | 0.020 |
Why?
|
Extremities | 1 | 2015 | 870 | 0.020 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2018 | 1536 | 0.020 |
Why?
|
Femoral Artery | 1 | 2014 | 829 | 0.020 |
Why?
|
Myocardial Infarction | 2 | 2023 | 11515 | 0.020 |
Why?
|
Carotid Arteries | 1 | 2014 | 943 | 0.020 |
Why?
|
Macaca mulatta | 1 | 2017 | 2363 | 0.020 |
Why?
|
Ligands | 1 | 2017 | 3281 | 0.020 |
Why?
|
Inflammation Mediators | 1 | 2018 | 1892 | 0.020 |
Why?
|
Animals, Newborn | 1 | 2015 | 2696 | 0.020 |
Why?
|
United States | 4 | 2020 | 73121 | 0.020 |
Why?
|
Energy Intake | 1 | 2017 | 2141 | 0.020 |
Why?
|
Angiotensin Receptor Antagonists | 1 | 2016 | 1066 | 0.020 |
Why?
|
Mitochondrial Proteins | 1 | 2015 | 979 | 0.020 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2016 | 1518 | 0.020 |
Why?
|
Osteogenesis | 1 | 2015 | 1296 | 0.020 |
Why?
|
Mortality | 1 | 2020 | 2917 | 0.020 |
Why?
|
Estrogen Replacement Therapy | 1 | 2015 | 1209 | 0.020 |
Why?
|
Gene Expression Regulation | 2 | 2017 | 11930 | 0.020 |
Why?
|
Evidence-Based Medicine | 1 | 2020 | 3708 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2015 | 4586 | 0.020 |
Why?
|
Aorta, Thoracic | 1 | 2014 | 1107 | 0.020 |
Why?
|
Reproducibility of Results | 2 | 2020 | 20231 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2017 | 6856 | 0.020 |
Why?
|
Menopause | 1 | 2015 | 1651 | 0.020 |
Why?
|
Health Promotion | 1 | 2019 | 2215 | 0.020 |
Why?
|
Mice, Inbred C57BL | 2 | 2015 | 22365 | 0.020 |
Why?
|
Bone Marrow | 1 | 2017 | 2929 | 0.020 |
Why?
|
Patient Satisfaction | 1 | 2019 | 3484 | 0.020 |
Why?
|
Biopsy | 1 | 2018 | 6816 | 0.020 |
Why?
|
Probability | 1 | 2011 | 2483 | 0.020 |
Why?
|
Erythrocytes | 1 | 2015 | 2422 | 0.020 |
Why?
|
Motor Activity | 1 | 2015 | 2722 | 0.020 |
Why?
|
Pilot Projects | 1 | 2019 | 8730 | 0.020 |
Why?
|
Lung Diseases | 1 | 2015 | 1926 | 0.020 |
Why?
|
Subcutaneous Fat | 1 | 2008 | 402 | 0.020 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2018 | 3408 | 0.010 |
Why?
|
Smoking Cessation | 1 | 2016 | 2079 | 0.010 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2016 | 2768 | 0.010 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2015 | 3612 | 0.010 |
Why?
|
Hemodynamics | 1 | 2014 | 4202 | 0.010 |
Why?
|
Gene Expression | 1 | 2016 | 7605 | 0.010 |
Why?
|
Electrocardiography | 1 | 2017 | 6410 | 0.010 |
Why?
|
Kidney Failure, Chronic | 1 | 2016 | 2489 | 0.010 |
Why?
|
Animals | 4 | 2017 | 169418 | 0.010 |
Why?
|
Neuropsychological Tests | 1 | 2016 | 7134 | 0.010 |
Why?
|
Survival Analysis | 1 | 2015 | 10125 | 0.010 |
Why?
|
Risk | 1 | 2014 | 9642 | 0.010 |
Why?
|
Alcohol Drinking | 1 | 2015 | 4052 | 0.010 |
Why?
|
Survival Rate | 1 | 2016 | 12875 | 0.010 |
Why?
|
Statistics as Topic | 1 | 2008 | 2362 | 0.010 |
Why?
|
Comorbidity | 1 | 2016 | 10601 | 0.010 |
Why?
|
Recurrence | 1 | 2014 | 8510 | 0.010 |
Why?
|
Research Design | 1 | 2017 | 6217 | 0.010 |
Why?
|
Analgesics, Opioid | 1 | 2017 | 3837 | 0.010 |
Why?
|
Linear Models | 1 | 2010 | 5880 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2015 | 12813 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 2018 | 10273 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2015 | 14480 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2018 | 12774 | 0.010 |
Why?
|
Ultrasonography | 1 | 2011 | 5995 | 0.010 |
Why?
|
Mice | 2 | 2015 | 82045 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2017 | 16029 | 0.010 |
Why?
|
Diabetes Mellitus | 1 | 2015 | 5887 | 0.010 |
Why?
|
Adolescent | 2 | 2018 | 89168 | 0.010 |
Why?
|
Anti-Bacterial Agents | 1 | 2014 | 7471 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2008 | 14728 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2015 | 20762 | 0.010 |
Why?
|